Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL B22GK 2 0 IN PLASTIC CONTAINER versus PRISMASOL BGK 2 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL B22GK 2 0 IN PLASTIC CONTAINER versus PRISMASOL BGK 2 3 5 IN PLASTIC CONTAINER.
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER vs PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol B22GK 2/0 is a solution used in continuous renal replacement therapy (CRRT) to correct electrolyte imbalances and remove waste products. It provides bicarbonate as a buffer via metabolism of lactate or acetate, and contains electrolytes to maintain homeostasis.
Prismasol BGK 2/3.5 is a sterile, non-pyrogenic hemofiltration solution used in continuous renal replacement therapy (CRRT). It does not have a pharmacological mechanism of action; rather, it provides electrolyte composition (sodium, potassium, calcium, magnesium, chloride, lactate) and glucose to replace fluid and electrolyte losses during hemofiltration or hemodialysis, maintaining acid-base balance and electrolyte homeostasis. The lactate in the solution serves as a bicarbonate precursor, metabolized to bicarbonate by the liver, helping to correct metabolic acidosis.
Continuous renal replacement therapy (CRRT): prescription as per institutional protocol, typically 2000-2500 mL/h effluent rate (dialysate + replacement fluid) for adults. Peritoneal dialysis: 2-3 L exchanges, 4-5 times daily or cycler. Intravenous infusion only via CRRT or as dialysate/replacement fluid.
PRISMASOL BGK 2/3.5 is a hemofiltration solution for continuous renal replacement therapy (CRRT). Administered intravenously via CRRT circuit. Typical adult dose: 1000-2000 mL/hour infusion rate adjusted to achieve effluent rate of 20-35 mL/kg/hour.
None Documented
None Documented
Not applicable; PRISMASOL B22GK 2/0 is a dialysate solution for CRRT. Components (glucose, electrolytes, lactate/bicarbonate) are continuously removed and replaced. For buffer conversion: lactate half-life ~5 minutes (hepatic metabolism to bicarbonate).
Not applicable as a single terminal half-life; components are endogenous substances with rapid turnover (e.g., lactate t1/2 ~10-20 min, electrolytes adjust within minutes to hours).
Renal (100%); eliminated unchanged by ultrafiltration and diffusion during continuous renal replacement therapy (CRRT). Biliary/fecal: negligible.
The components are primarily excreted renally: sodium, potassium, and glucose are eliminated via urine; bicarbonate is consumed or excreted as CO2; lactate is metabolized to bicarbonate. ~100% renal for electrolytes.
Category C
Category C
Dialysis Solution
Dialysis Solution